PMDA drug package insert
チガソンカプセル10
PMDA Prescription drug · 太陽ファルマ株式会社 · package insert Jan 24, 2024
Key facts
| Brand names | チガソンカプセル10, チガソンカプセル25 |
|---|---|
| Nonproprietary names | エトレチナート |
| Companies | 製造販売元／太陽ファルマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 角化症治療剤 |
| Therapeutic category codes | 873119 |
| YJ codes | 3119001M1020, 3119001M2027 |
| Approval numbers | 16000AMZ00020, 16000AMZ00021 |
| Package insert edition | 第2版 |
| Package insert date | Jan 24, 2024 |
| PMDA document key | 431010_3119001M1020_3 |
| PMDA company code | 431010 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: